Alex Schwartz's Stock Ratings

Stifel Analyst

Alex Schwartz is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/11/2025

Overall Average Return

9.19%

Smart Score

42.8%

Overall Average Return Percentile

58th

Number of Ratings

17
Buy NowGet Alert
02/21/2024ANABBuy Now
AnaptysBio
$23.36114.04%
Alex Schwartz42%
→ $50Initiates → BuyGet Alert
09/14/2018ANABBuy Now
AnaptysBio
$23.36443.66%
Alex Schwartz42%
→ $127Reinstates → BuyGet Alert
04/10/2018VTVTBuy Now
vTv Therapeutics
$16.36
Alex Schwartz42%
DowngradeBuy → HoldGet Alert
03/27/2018ANABBuy Now
AnaptysBio
$23.36550.68%
Alex Schwartz42%
$139 → $152MaintainsBuyGet Alert
03/19/2018GERNBuy Now
Geron
$1.57154.78%
Alex Schwartz42%
$2.5 → $4MaintainsHoldGet Alert
03/09/2018PBYIBuy Now
Puma Biotechnology
$3.602538.89%
Alex Schwartz42%
$85 → $95MaintainsBuyGet Alert
03/06/2018ANABBuy Now
AnaptysBio
$23.36495.03%
Alex Schwartz42%
$130 → $139MaintainsBuyGet Alert
02/27/2018CLVSBuy Now
Clovis Oncology
Alex Schwartz42%
$125 → $110MaintainsBuyGet Alert
09/21/2016PBYIBuy Now
Puma Biotechnology
$3.60
Alex Schwartz42%
UpgradeHold → BuyGet Alert
08/24/2015VTVTBuy Now
vTv Therapeutics
$16.363.91%
Alex Schwartz42%
→ $17Initiates → BuyGet Alert
05/18/2015CLVSBuy Now
Clovis Oncology
Alex Schwartz42%
$90 → $125MaintainsBuyGet Alert
02/26/2015CLVSBuy Now
Clovis Oncology
Alex Schwartz42%
$75 → $90MaintainsBuyGet Alert
11/07/2014CLVSBuy Now
Clovis Oncology
Alex Schwartz42%
$50 → $75MaintainsBuyGet Alert
06/05/2014CLVSBuy Now
Clovis Oncology
Alex Schwartz42%
UpgradeHold → BuyGet Alert
12/19/2013PBYIBuy Now
PUMA BIOTECHNOLOGY
$3.60
Alex Schwartz42%
DowngradeBuy → HoldGet Alert
09/06/2013CLVSBuy Now
Clovis Oncology
Alex Schwartz42%
Initiates → HoldGet Alert
08/24/2012PBYIBuy Now
Puma Biotechnology
$3.60427.78%
Alex Schwartz42%
→ $19Initiates → BuyGet Alert